Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EPE Special Opportunities Limited | EP0 | Jan 30, 2025 | 1.57 | +1.29 |
EPENDION AB SK 0,3333 | TW4 | Jan 30, 2025 | 8.86 | -0.56 |
Epigenomics AG | ECX | Jan 30, 2025 | 1.25 | 0.00 |
Epiroc A | 3AD1 | Jan 30, 2025 | 18.79 | -1.65 |
EPIROC AB UNSP.ADR/1 | 3ADA | Jan 30, 2025 | 18.30 | -1.08 |
Epiroc B | 3AD2 | Jan 30, 2025 | 16.57 | -1.02 |
Episurf Medical B | 16E | Jan 30, 2025 | 0.00 | +45.45 |
ePlus inc. | MLE | Jan 30, 2025 | 75.00 | 0.00 |
EPR Properties | E2H | Jan 30, 2025 | 44.77 | -1.40 |
EPRCOMUNICAZIONE S.P.A. | J3P | Jan 30, 2025 | 1.18 | +6.31 |
EPTI AB AK | G7H0 | Jan 30, 2025 | 8.36 | +11.76 |
Epwin Group Plc | 2E3 | Jan 30, 2025 | 1.04 | -2.80 |
EQB INC. | V22 | Jan 30, 2025 | 73.00 | -2.01 |
EQL Pharma | 7JK | Jan 30, 2025 | 6.48 | -3.28 |
EQT | 6EQ | Jan 30, 2025 | 30.84 | -0.36 |
EQT Corporation | EQ6 | Jan 30, 2025 | 48.59 | +1.94 |
Eqtec | KEU | Jan 30, 2025 | 0.01 | -28.57 |
Equals Group Plc | 2FX | Jan 30, 2025 | 1.56 | 0.00 |
Equatorial Resources Limited | PBU | Jan 30, 2025 | 0.07 | +0.76 |
Equifax, Inc. | EFX | Jan 30, 2025 | 260.00 | -0.76 |
Equillium, Inc. | 0FY | Jan 30, 2025 | 0.59 | -4.96 |
Equinix, Inc. | EQN2 | Jan 30, 2025 | 867.60 | +0.51 |
Equinor | DNQ | Jan 30, 2025 | 23.31 | +1.68 |
Equinor ASA | DNQA | Jan 30, 2025 | 23.00 | +0.88 |
Equinox Gold Corp | 1LRC | Jan 30, 2025 | 5.79 | +4.82 |
EQUIPMAKE HLDGS LS -,0001 | U8O | Jan 30, 2025 | 0.01 | 0.00 |
Equitable Holdings Inc | AXJ | Jan 30, 2025 | 51.00 | +0.99 |
Equity Bancshares, Inc. - Class A | 44X | Jan 30, 2025 | 41.20 | 0.00 |
Equity Commonwealth | HP5A | Jan 30, 2025 | 1.59 | -1.24 |
Equity Lifestyle Properties, Inc. | MHV | Jan 30, 2025 | 62.50 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.